Series E - $500M
|Investors:||T. Rowe Price
Viking Global Investors
Color Health provides the infrastructure to support durable and equitable public health across entire populations. Color’s technology and clinical services are the backbone of large-scale population health programs for over 200 institutions worldwide, with data and services spanning hereditary cancers, heart disease, infectious disease testing (including COVID-19), and community-based vaccination programs. Using a data driven approach, we’re democratizing access to health care insights.
In March of 2020, when the threat of COVID-19 became more apparent and impacted more lives, our team came together to decide how we could contribute to finding a solution to the testing crisis in the US. We used our expertise in population-scale testing and automation to solve for COVID-19 testing bottlenecks and increase testing access. We have now returned nearly 6M COVID-19 test results and support 4K testing sites across the country. Color has also completed more than 1M vaccine appointments across Massachusetts and California.
Looking ahead, we’re continuing to support our partners and customers as the need for COVID-19 testing and vaccine distribution evolves. Even beyond the pandemic, Color is poised to provide the infrastructure and capabilities to monitor, manage, and protect the health of large populations that are represented by governments, employers, & schools.